Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice
- 31 August 2008
- Vol. 43 (2) , 264-273
- https://doi.org/10.1016/j.bone.2008.03.024
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A Population-Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and MenJournal of Bone and Mineral Research, 2008
- Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosisOsteoporosis International, 2007
- Mechanisms of Anabolic Therapies for OsteoporosisNew England Journal of Medicine, 2007
- Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune responseGenes & Immunity, 2007
- T Lymphocyte–Deficient Mice Lose Trabecular Bone Mass With OvariectomyJournal of Bone and Mineral Research, 2006
- Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null miceMatrix Biology, 2005
- Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone lossAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Parathyroid hormone and parathyroid hormone-related peptide, and their receptorsBiochemical and Biophysical Research Communications, 2004
- Resistance to Unloading-Induced Three-Dimensional Bone Loss in Osteopontin-Deficient MiceJournal of Bone and Mineral Research, 2002
- Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell FormationEndocrinology, 1999